We show that downregulation of Mcl-1 by Mcl-1 siRNA or inhibiting ERK1/2 through U0126 or nitric oxide treatment increased the sensitivity of breast cancer cells to CHX-induced apoptosis. This evidence concerns the gene MAPK3 and breast carcinoma.